Medindia

X

IMRISneuro at Central DuPage Hospital will be the first in the Chicago area

Thursday, August 7, 2008 General News J E 4
Advertisement
WINNIPEG, Aug. 6 /PRNewswire-FirstCall/ - IMRIS (TSX: IM) announced today that it will be installing its fully integrated intraoperative imaging suite IMRISneuro at Central DuPage Hospital (CDH) in Winfield, Illinois, a suburb west of Chicago. Installation of this leading edge technology is planned for early 2009.

CDH, one of the fastest growing hospitals in the region, will be the first in Chicago to implement this revolutionary imaging technology. Recognized nationally as a leader in technology and patient safety, CDH has made IMRISneuro an integral component in the continued expansion of its Neurosciences Institute.

Central DuPage Hospital will be one of only 18 hospitals in the world to house IMRISneuro; a fully integrated operating room that combines a one-of-a-kind movable high-field MRI with the IMRIS surgical information management system.

"This technology is a distinct advantage for our patients and surgeons," said Vice President of Operations at CDH, Robert Friedberg. "Nowhere else in the Chicago region is there an operating room facility that merges the capabilities of a high field magnet with a state of the art neuro-operating room. Surgeons will be able to scan patients while still in the operating room, and determine the extent or completion of tumor removal. Patients will be able to have the confidence that their surgeon has this great additional tool to help them on the road to recovery."

"We are confident that in the hands of the surgeons at Central DuPage Hospital, IMRISneuro will make a major contribution towards providing Chicago area patients with the highest standard of neuroscience treatment and care," said IMRIS President and Chief Executive Officer David Graves.

IMRISneuro does not require the patient to be transported for scanning, so the optimum position for neurosurgery is never compromised. Clinical workflow and surgical access to the patient is not impacted and the magnet is removed completely from the operating room when scanning is complete.

According to Taras Masnyk, MD of the Neurosciences Institute at CDH, "Being able to remove more of the tumor, or being able to see that the tumor is completely removed before closing will favorably impact the long-term survivability of these critically ill patients."



About IMRIS: IMRIS (TSX: IM) is a global leader in providing fully integrated, advanced surgical imaging solutions designed to measurably improve patient outcomes. The company's flagship product, IMRISneuro, utilizes patented technology that allows a high field MRI scanner to move in to the operating room on demand, providing imaging during the surgical procedure without compromising patient safety. This unique and innovative system has been validated by leading neurosurgeons around the world for use in world-class neuroscience centers.

For more information, visit www.imris.com



About Central DuPage Hospital: Central DuPage Hospital (CDH) is a nationally recognized 313-bed facility located in Winfield, Illinois, a suburb west of Chicago. This regional referral center houses the Neurosciences Institute at CDH, covering a full range of neurosciences care, as well as innovation and research. With continuous specialized neurology, neurosurgery and interventional neuroradiology coverage, the Neurosciences Institute at CDH is one of the region's largest and most comprehensive stroke and epilepsy centers. CDH, a leader in technology and innovation, is one of the largest performers of surgery in Illinois.

The hospital is part of an interdependent network of health-care organizations and services, including convenient care centers, occupational health services and a full range of options for senior living, home health and hospice care. To learn more information about CDH, visit www.cdh.org or call (630) 933-4CDH.



SOURCE IMRIS Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Caliper Life Sciences Reports Second Quarter 2008 ...
S
Ondine to Present at Canaccord Adams 28th Annual G...